________________________________________________________________________________________________________________________
to deliver innovative solutions of the highest quality to the people that most need them.”
Haraldur goes on to outline the extensive range of products the business supplies:“ Globus offers a complete solution for safety equipment and PPE, specializing in hand, eye, head, hearing, and respiratory protection as well as protective clothing. The solutions offered extend way beyond just products, with services like the 360 Program and a prescription eyewear portal designed to enhance safety right across a site or end-user business. The Globus 360 Safety Program is a free, no-obligation, tailor-made service to help assess and identify the specific PPE needs for a particular site or workplace. Our solutions are applicable to a diverse range of industries such as construction, oil and gas, healthcare, manufacturing and chemical.”
On top of significant recent successes, Globus began 2025 with a significant acquisition, Global Glove in the US, which has bolstered its international presence and expanded its production capabilities. Haraldur elaborates, highlighting the benefits the acquisition has brought to the company:“ With excellent year-on-year growth, the joining of forces will provide Globus Americas with the infrastructure and sales support needed to take the business to a new level. The combined capability of both businesses enables us to offer a broader portfolio of products and services, with extensive stockholding. Our businesses have more than 50 years of experience in the global PPE manufacturing industry, and we will continue to bring expertise, quality, range, depth, and enhanced service to the market.”
The move represents a broader investment and growth strategy which has also seen significant investments made in the UK, as Haraldur
explains:“ Globus is investing heavily in manufacturing across multiple sites in the UK, Germany, Italy, USA, and has plans in place for Mexico. The business has a fully integrated UK manufacturing capability including a melt blown production facility. The key is to offer support and resilience, de-risking market forces and reducing the supply chain risk for our core partners across both industry and healthcare. With important lessons from the pandemic, appropriate PPE stock should be available to partners like the NHS on shorter lead times with lower reliance on supply from the Far East.
“ We can stay at the cutting edge of innovation through our extensive research and development programs. Inhouse technical design, quality assurance and a testing lab enable market
236